Caris Life Sciences, Inc. (CAI)
Automate Your Wheel Strategy on CAI
With Tiblio's Option Bot, you can configure your own wheel strategy including CAI - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol CAI
- Rev/Share 4.6568
- Book/Share 6.9764
- PB 4.4167
- Debt/Equity 0.9251
- CurrentRatio 9.2406
- ROIC -0.0458
- MktCap 8666590027.0
- FreeCF/Share -0.4332
- PFCF -308.1454
- PE -11.4716
- Debt/Assets 0.4387
- DivYield 0
- ROE 0.1624
- Rating D+
- Score 1
- Recommendation Strong Sell
- P/E Score 1
- DCF Score 1
- P/B Score 2
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | CAI | BofA Securities | -- | Buy | -- | $31 | July 14, 2025 |
| Initiation | CAI | BTIG Research | -- | Buy | -- | $38 | July 14, 2025 |
| Initiation | CAI | Citigroup | -- | Buy | -- | $34 | July 14, 2025 |
| Initiation | CAI | Evercore ISI | -- | Outperform | -- | $33 | July 14, 2025 |
| Initiation | CAI | Guggenheim | -- | Buy | -- | $32 | July 14, 2025 |
| Initiation | CAI | JP Morgan | -- | Overweight | -- | $31 | July 14, 2025 |
| Initiation | CAI | TD Cowen | -- | Buy | -- | $32 | July 14, 2025 |
| Initiation | CAI | Wolfe Research | -- | Outperform | -- | $32 | July 14, 2025 |
News
Caris Life Sciences: Impressive Growth, But Lock-Up Expiry Looms
Published: September 19, 2025 by: Seeking Alpha
Sentiment: Neutral
Caris Life Sciences stands out for its broad molecular and AI-driven cancer diagnostics but faces upcoming volatility as the IPO lock-up expires on 15 December 2025. CAI's revenue growth is robust, driven primarily by molecular profiling, but overdependence on this segment and execution across diverse fronts pose risks. The company boasts industry-leading breadth—tissue and blood testing, early detection, monitoring, and biopharma partnerships—but faces strong, focused competitors in each segment.
Read More
U.S. IPO Weekly Recap: Sizable Precision Medicine And Insurance IPOs Raise A Combined $902 Million
Published: June 22, 2025 by: Seeking Alpha
Sentiment: Positive
A handful of IPOs and blank checks priced in the short holiday week, led by two sizable issuers. Two smaller IPOs also priced this past week. One IPO is currently scheduled to list in the week ahead, although some small names may also join the calendar throughout the week.
Read More
About Caris Life Sciences, Inc. (CAI)
- IPO Date 2025-06-18
- Website https://www.carislifesciences.com
- Industry Biotechnology
- CEO David Dean Halbert
- Employees 1769